$5.01 -0.10 (-1.96%)
3/12/2010 4:00 PM

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Results 1 - 11 of 11

Recs

0
Member Avatar zzlangerhans (99.51) Submitted: 11/18/2009 9:58:41 AM : Outperform Start Price: $5.12 IDRA Score: -6.31

Rather than an endorsement of Idera's pipeline, this green thumb represents confidence in their low burn and the volatility of the stock. Having stabilized off a recent spike and plunge (for no discernible reason), Idera is primed to reascend and has all the time in the world to get there.

Recs

0
Member Avatar ScreenerStizBear (< 20) Submitted: 6/26/2008 2:26:22 PM : Underperform Start Price: $14.63 IDRA Score: +58.10

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recs

0
Member Avatar goldnrtrvrlvr (< 20) Submitted: 5/5/2008 7:24:39 AM : Outperform Start Price: $14.75 IDRA Score: -50.92

New Hi

Recs

0
Member Avatar fouadtawfig (< 20) Submitted: 4/16/2008 11:27:35 AM : Outperform Start Price: $13.03 IDRA Score: -50.11

exiting patents needed for farmuecitical market will reflect son expanded orders and deman for larger supply.

Recs

0
Member Avatar mbeleza (< 20) Submitted: 11/14/2007 5:56:55 AM : Underperform Start Price: $12.15 IDRA Score: +39.83

It´s at it's most

Recs

0
Member Avatar eXigy (98.65) Submitted: 9/5/2007 2:59:30 PM : Underperform Start Price: $8.80 IDRA Score: +25.47

Not a long-termie, because I'm not personally well into the stock and cannot tell whether they have something unique in their safes to take it out by Easter or not.
But I can tell a stock with such stats and such current price is to go down.

Recs

0
Member Avatar fire0821 (< 20) Submitted: 6/21/2007 10:12:51 PM : Outperform Start Price: $6.87 IDRA Score: -7.29

pharmaceuticals are always fluctuating up and down according to the seasons. summer is a down season.

Recs

0
Member Avatar TyPicks (< 20) Submitted: 2/8/2007 11:02:07 AM : Outperform Start Price: $9.40 IDRA Score: -31.61

Wall Street Pro Pick.

Recs

0
Member Avatar davezzzz (24.67) Submitted: 1/26/2007 7:51:21 PM : Outperform Start Price: $7.67 IDRA Score: -20.87

Hey - it's just a random pick from the top performers list. What do I know? (not much)

Recs

1
Member Avatar lemapud (< 20) Submitted: 1/22/2007 5:20:24 PM : Outperform Start Price: $7.70 IDRA Score: -21.08

IDERA has cutting edge new science in the field of immunology. They have had their share of followers and detractors over the years, and survived through it all. They have a strong company plan now, good partners, and exciting therapies that will be used to combat aids, cancer, and other human maladies. Above all IDERA has always been an honest, intelligent company that had strived to make a difference in health and science.

Recs

0
Member Avatar martinlemalin (70.88) Submitted: 1/20/2007 4:34:19 PM : Outperform Start Price: $7.55 IDRA Score: -19.30

.. I'd give this one a thumbs up ..

Results 1 - 11 of 11

Featured Broker Partners